This company listing is no longer active
Bionomics Balance Sheet Health
Financial Health criteria checks 6/6
Bionomics has a total shareholder equity of A$47.7M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$56.3M and A$8.6M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$30.70m |
| Equity | AU$47.72m |
| Total liabilities | AU$8.59m |
| Total assets | AU$56.31m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: B1N's short term assets (A$33.1M) exceed its short term liabilities (A$3.7M).
Long Term Liabilities: B1N's short term assets (A$33.1M) exceed its long term liabilities (A$4.9M).
Debt to Equity History and Analysis
Debt Level: B1N is debt free.
Reducing Debt: B1N has no debt compared to 5 years ago when its debt to equity ratio was 63.9%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: B1N has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: B1N has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 9% each year.